(0.17%) 5 140.00 points
(0.11%) 38 482 points
(0.24%) 17 889 points
(-0.36%) $83.55
(1.61%) $1.954
(0.11%) $2 349.70
(0.54%) $27.68
(1.19%) $933.05
(-0.02%) $0.935
(-0.10%) $11.01
(-0.15%) $0.799
(1.33%) $93.09
Live Chart Being Loaded With Signals
M1 Kliniken AG, together with its subsidiaries, operates medical centers for aesthetic and plastic surgery in Germany, Austria, the Netherlands, Switzerland, the United Kingdom, Croatia, and Australia...
Stats | |
---|---|
本日の出来高 | 6 256.00 |
平均出来高 | 22 459.00 |
時価総額 | 243.40M |
EPS | €0 ( 2024-04-18 ) |
Last Dividend | €0.300 ( 2019-08-26 ) |
Next Dividend | €0 ( N/A ) |
P/E | 41.72 |
ATR14 | €0.105 (0.79%) |
ボリューム 相関
M1 Kliniken AG 相関
10 最も正の相関 |
---|
10 最も負の相関 |
---|
知っていましたか?
相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。
相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。
M1 Kliniken AG 相関 - 通貨/商品
M1 Kliniken AG 財務諸表
Annual | 2022 |
収益: | €285.29M |
総利益: | €21.72M (7.61 %) |
EPS: | €0.240 |
FY | 2022 |
収益: | €285.29M |
総利益: | €21.72M (7.61 %) |
EPS: | €0.240 |
FY | 2021 |
収益: | €314.61M |
総利益: | €55.31M (17.58 %) |
EPS: | €0.450 |
FY | 2020 |
収益: | €159.59M |
総利益: | €36.78M (23.05 %) |
EPS: | €0.370 |
Financial Reports:
No articles found.
M1 Kliniken AG Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
€0 (N/A) |
€0 (N/A) |
€0 (N/A) |
€0 (N/A) |
€0 (N/A) |
€0 (N/A) |
€0 (N/A) |
€0 (N/A) |
€0 (N/A) |
€0 (N/A) |
First Dividend | €0.300 | 2016-06-16 |
Last Dividend | €0.300 | 2019-08-26 |
Next Dividend | €0 | N/A |
Payout Date | 2019-08-28 | |
Next Payout Date | N/A | |
# dividends | 4 | -- |
Total Paid Out | €1.200 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 2.49 | -- |
Div. Sustainability Score | 8.56 | |
Div.Growth Potential Score | 4.43 | |
Div. Directional Score | 6.49 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
THYG.F | Ex Dividend Junior | 2023-08-21 | Semi-Annually | 0 | 0.00% | |
DGR.DE | Ex Dividend Junior | 2023-06-28 | Annually | 0 | 0.00% | |
MRK.DE | Ex Dividend Knight | 2023-05-02 | Annually | 0 | 0.00% | |
5Y7.F | Ex Dividend Knight | 2023-08-08 | Semi-Annually | 0 | 0.00% | |
W8A.DE | Ex Dividend Junior | 2023-08-18 | Quarterly | 0 | 0.00% | |
FC9.DE | Ex Dividend Junior | 2023-06-14 | Annually | 0 | 0.00% | |
ORC.DE | Ex Dividend Knight | 2023-10-11 | Quarterly | 0 | 0.00% | |
AOMD.DE | No Dividend Player | 2023-07-17 | Sporadic | 0 | 0.00% | |
HBH.DE | Ex Dividend Junior | 2023-07-10 | Annually | 0 | 0.00% | |
RNL.DE | Ex Dividend Junior | 2023-05-17 | Sporadic | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0214 | 1.500 | 9.57 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0313 | 1.200 | 8.96 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0663 | 1.500 | -0.375 | -0.562 | [0.1 - 1] |
payoutRatioTTM | 0.287 | -1.000 | 7.13 | -7.13 | [0 - 1] |
currentRatioTTM | 2.73 | 0.800 | 1.338 | 1.070 | [1 - 3] |
quickRatioTTM | 2.01 | 0.800 | 2.89 | 2.31 | [0.8 - 2.5] |
cashRatioTTM | 0.552 | 1.500 | 8.04 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.0333 | -1.500 | 9.45 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 12.29 | 1.000 | 6.56 | 6.56 | [3 - 30] |
operatingCashFlowPerShareTTM | 0.721 | 2.00 | 9.76 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 0.641 | 2.00 | 9.68 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.0689 | -1.500 | 9.72 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.0844 | 1.000 | -1.926 | -1.926 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0409 | 1.000 | -1.183 | -1.183 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 1.946 | 1.000 | 0.302 | 0.302 | [0.2 - 2] |
assetTurnoverTTM | 1.463 | 0.800 | 3.58 | 2.86 | [0.5 - 2] |
Total Score | 8.56 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 38.15 | 1.000 | 6.25 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0663 | 2.50 | -0.241 | -0.562 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 0.641 | 2.00 | 9.79 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 0.721 | 2.00 | 9.76 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.287 | 1.500 | 7.13 | -7.13 | [0 - 1] |
pegRatioTTM | 0.910 | 1.500 | 7.27 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0442 | 1.000 | -1.394 | 0 | [0.1 - 0.5] |
Total Score | 4.43 |
M1 Kliniken AG
M1 Kliniken AG, together with its subsidiaries, operates medical centers for aesthetic and plastic surgery in Germany, Austria, the Netherlands, Switzerland, the United Kingdom, Croatia, and Australia. The company operates in two segments, Beauty and Trade. It develops and markets pharmaceutical, medical, and medical technology products for aesthetic medicine and cosmetic dermatology, as well as trades in pharmaceutical, biosimilars, and other medical products and devices in the areas of oncology, HIV, rheumatism, neurology, cardiovascular diseases, and narcotics. The company also engages in the acquisition, management, and sale of real estate, primarily in the health care sector. It offers its products to doctors, pharmacies, and wholesalers under the M1 Select brand. The company operates a network of outpatient specialist centers; and a specialized surgical clinic center, as well as 46 specialist centers under the M1 Med Beauty brand. M1 Kliniken AG was founded in 2007 and is based in Berlin, Germany. M1 Kliniken AG operates as a subsidiary of MPH Health Care AG.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。